Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (319)
ARTG (259)
Prescription medicine registration (23)
Designation or determination (2)
Prescription medicine evaluation (2)

Date

2025 (27)
2024 (51)
2023 (161)
2022 (30)
2021 (55)
2020 (48)
2019 (26)
2018 (53)
2017 (35)
2016 (77)
2015 (2)
2014 (2)
2013 (9)
2012 (10)
2011 (2)
2010 (10)
2008 (2)
2002 (2)
2001 (3)

Search

Sponsor content

605 result(s) found, displaying 91 to 100

RIVAROXABAN-REDDY'S rivaroxaban 20 mg tablet blister pack (290213)

4 January 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-REDDY'S rivaroxaban 20 mg tablet blister pack.
NICABATE MINI LOZENGES nicotine 2 mg (as polacrilex) mint flavour lozenge tube (392045)

11 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NICABATE MINI LOZENGES nicotine 2 mg (as polacrilex) mint flavour lozenge tube.
NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation) (392046)

11 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation).
ALENDRONATE PLUS D3 70 mg/140 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
FONATPLUS 70 mg/70 ug alendronate (as sodium) and colecalciferol 70 mg/70 microgram (2800 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
FONATPLUS 70 mg/140 ug alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 70 mg/70 ug APOTEX alendronate (as sodium) 70 mg and colecalciferol 70 microgram (2800 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
SILDENAFIL GENERICHEALTH Sildenafil (as citrate) 50 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
SILDENAFIL GENERICHEALTH Sildenafil (as citrate) 25 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ALENDRONATE PLUS D3 SANDOZ 70 mg/140 microgram alendronate (as sodium) 70 mg and colecalciferol 140 microgram (5600 IU) tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2023

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd

Pages

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.